MTP835B - Imidazole derivatives - Google Patents

Imidazole derivatives

Info

Publication number
MTP835B
MTP835B MT835A MTP835A MTP835B MT P835 B MTP835 B MT P835B MT 835 A MT835 A MT 835A MT P835 A MTP835 A MT P835A MT P835 B MTP835 B MT P835B
Authority
MT
Malta
Prior art keywords
imidazole derivatives
imidazole
derivatives
Prior art date
Application number
MT835A
Other languages
English (en)
Inventor
Anna Krasso
Ernst-Peter Krebs
Original Assignee
Hoffman La Roche And Co Aktien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffman La Roche And Co Aktien filed Critical Hoffman La Roche And Co Aktien
Publication of MTP835B publication Critical patent/MTP835B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MT835A 1977-09-19 1978-09-18 Imidazole derivatives MTP835B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU78140 1977-09-19
CH814978 1978-07-28

Publications (1)

Publication Number Publication Date
MTP835B true MTP835B (en) 1979-11-14

Family

ID=25702876

Family Applications (1)

Application Number Title Priority Date Filing Date
MT835A MTP835B (en) 1977-09-19 1978-09-18 Imidazole derivatives

Country Status (36)

Country Link
US (2) US4182766A (en:Method)
EP (1) EP0001279B1 (en:Method)
JP (1) JPS5459274A (en:Method)
AR (1) AR224350A1 (en:Method)
AT (1) AT368152B (en:Method)
AU (1) AU519711B2 (en:Method)
BG (1) BG28708A3 (en:Method)
BR (1) BR7806148A (en:Method)
CA (1) CA1106849A (en:Method)
DD (1) DD138210A5 (en:Method)
DE (2) DE2861237D1 (en:Method)
DK (1) DK406578A (en:Method)
EG (1) EG13530A (en:Method)
ES (1) ES473451A1 (en:Method)
FI (1) FI64365C (en:Method)
FR (1) FR2403340A1 (en:Method)
GB (1) GB2004281B (en:Method)
GR (1) GR73069B (en:Method)
HU (1) HU176111B (en:Method)
IE (1) IE47363B1 (en:Method)
IL (1) IL55557A (en:Method)
IN (1) IN148930B (en:Method)
IT (1) IT1098858B (en:Method)
MC (1) MC1213A1 (en:Method)
MT (1) MTP835B (en:Method)
NL (1) NL7809529A (en:Method)
NO (1) NO149962C (en:Method)
NZ (1) NZ188405A (en:Method)
OA (1) OA06054A (en:Method)
PH (1) PH16342A (en:Method)
PL (1) PL114494B1 (en:Method)
PT (1) PT68573A (en:Method)
RO (1) RO75258A (en:Method)
SE (1) SE7809792L (en:Method)
SU (1) SU793390A3 (en:Method)
YU (1) YU216778A (en:Method)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4321372A (en) * 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
IL66340A (en) * 1981-08-13 1986-08-31 Haessle Ab Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
IL71665A (en) * 1983-05-03 1988-05-31 Byk Gulden Lomberg Chem Fab Fluoro-(2-pyridyl-methylthio)-dioxolo-(and dioxino-)benzimidazoles,processes for their preparation and pharmaceutical compositions containing the same
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
EP0174717B1 (en) * 1984-07-06 1992-01-22 FISONS plc Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
AU5768886A (en) 1985-05-24 1986-11-27 G.D. Searle & Co. 2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
SE8600658D0 (sv) * 1986-02-14 1986-02-14 Haessle Ab Novel composition of matter
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
SE8604998D0 (sv) 1986-11-21 1986-11-21 Haessle Ab Novel pharmacological compounds
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
DE3701277A1 (de) * 1987-01-17 1988-07-28 Boehringer Mannheim Gmbh Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
SE8804628D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New compounds
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5049674A (en) 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
EP0649305A1 (en) * 1992-07-08 1995-04-26 Monsanto Company Benzimidazoles for alleviating stomach ulcers in swine
US5945425A (en) * 1994-04-29 1999-08-31 G.D. Searle & Co. Method of using (H+ /K+)ATPase inhibitors as antiviral agents
PT1092434E (pt) * 1995-09-21 2004-08-31 Pharma Pass Ii Llc Composicao farmaceutica contendo um benzimidazole acido-labil e processo para a sua preparacao
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
KR100463031B1 (ko) * 1997-05-26 2005-04-06 동아제약주식회사 5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) * 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
WO2005007117A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
EP2068841B1 (en) 2006-10-05 2018-09-26 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
EP4598528A1 (en) 2022-10-04 2025-08-13 Arsenil Zabirnyk Inhibition of aortic valve calcification

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985661A (en) * 1956-02-06 1961-05-23 American Cyanamid Co Preparation of 2(omicron-aminophenyl)-benzimidazole
GB1234058A (en:Method) * 1968-10-21 1971-06-03
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen

Also Published As

Publication number Publication date
PL209693A1 (pl) 1979-06-04
DE2861237D1 (en) 1981-12-10
FR2403340A1 (fr) 1979-04-13
RO75258A (ro) 1980-11-30
GB2004281A (en) 1979-03-28
ATA673378A (de) 1982-01-15
MC1213A1 (fr) 1979-05-18
ES473451A1 (es) 1979-05-01
EP0001279B1 (de) 1981-09-30
BR7806148A (pt) 1979-04-17
OA06054A (fr) 1981-06-30
SU793390A3 (ru) 1980-12-30
NL7809529A (nl) 1979-03-21
NO149962C (no) 1984-07-25
JPS5459274A (en) 1979-05-12
SE7809792L (sv) 1979-03-20
YU216778A (en) 1983-01-21
FI64365C (fi) 1983-11-10
DK406578A (da) 1979-03-20
BG28708A3 (bg) 1980-06-16
US4182766A (en) 1980-01-08
AU519711B2 (en) 1981-12-17
EP0001279A1 (de) 1979-04-04
NZ188405A (en) 1981-03-16
GR73069B (en:Method) 1984-01-30
FI782847A7 (fi) 1979-03-20
HU176111B (en) 1980-12-28
AU3981778A (en) 1980-03-20
CA1106849A (en) 1981-08-11
IT7827861A0 (it) 1978-09-19
PT68573A (fr) 1978-10-01
IE47363B1 (en) 1984-03-07
NO783155L (no) 1979-03-20
DD138210A5 (de) 1979-10-17
FR2403340B1 (en:Method) 1981-02-13
GB2004281B (en) 1982-03-10
IN148930B (en:Method) 1981-07-25
EG13530A (en) 1981-12-31
DE2840591A1 (de) 1979-03-29
IE781878L (en) 1979-03-19
PL114494B1 (en) 1981-01-31
IT1098858B (it) 1985-09-18
PH16342A (en) 1983-09-05
NO149962B (no) 1984-04-16
IL55557A0 (en) 1978-12-17
AT368152B (de) 1982-09-27
IL55557A (en) 1982-02-28
US4248880A (en) 1981-02-03
AR224350A1 (es) 1981-11-30
FI64365B (fi) 1983-07-29

Similar Documents

Publication Publication Date Title
GB2004281B (en) Imidazole derivatives
GB2003154A (en) Nitroimidazole derivatives
JPS5395973A (en) Azole derivatives
AU4113878A (en) 1-alkanoyl-proline derivatives
GB2003876A (en) Beta-haloethylamine derivatives
GB1557019A (en) Metalsulphonamido-benzamide derivatives
ZA781229B (en) Imidazole derivatives
AU3569678A (en) Benzimidazole derivatives
GB2008579B (en) 2-imino-imidazolidine derivatives
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
GB2009180B (en) 25-alkylcholestrerol derivatives
GB2009150B (en) Tetrahydrophtalamide derivatives
GB2005261B (en) 2-oxazolydone derivatives
GB2014131B (en) 1-hydrocarbylpyrrole derivatives
GB2003479B (en) 3-amino-17alpha-aza-d-homoandrostane derivatives
ZA781585B (en) Imidazole derivatives
AU3313978A (en) Everninomicin derivatives
GB2000128B (en) 15-substituted-omega-pentanorprostaglandin derivatives
GB2000769B (en) 4 - homoisotwistane derivatives
IL53350A0 (en) Imidazole derivatives
GB2008119B (en) Arylsteroid derivatives
MW2478A1 (en) Imidazole derivatives
IE810213L (en) Imidazole derivatives
GB2003855B (en) Triphenylbut-1-ene derivatives
GB2002776B (en) Peruvoside derivatives